Emily Beman is an associate in the firm’s Technology Transactions practice and Technology & Life Sciences Group. She joined Goodwin in 2010.

Areas of Practice
TÄTIGKEITSFELDER
Domaines D’Expertise
业务范围

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

A selection of Ms. Beman’s recent representative matters is below.

  • CRISPR Therapeutics in its collaboration with Vertex Pharmaceuticals, valued up to $2.6 billion with $105 million upfront
  • CRISPR Therapeutics in its collaboration with Bayer, valued up to $635 million with $335 million upfront
  • CRISPR Therapeutics in its strategic in-licensing and collaboration agreement with Anagenesis Biotechnologies
  • F-star Alpha in its exclusive purchase option agreement with Bristol-Myers Squibb with potential deal value up to $475 million
  • Naurex in its $560 million sale to Allergan
  • Cephalon in its exclusive license agreement with Eagle Pharmaceuticals with a total deal value in excess of $120 million, plus royalties
  • Teva Pharmaceuticals, in its $40.5 billion acquisition of Allergan’s (fka Actavis/Watson) Global Generic Pharmaceuticals Business.
  • Teva Pharmaceuticals, in connection with its sale of oncology assets to Ignyta
  • Teva Pharmaceuticals, in connection with patent license and settlement agreements related to settlements of various brand and generic pharmaceutical patent litigation matters
  • Licensing of intellectual property assets from research institutions
Professional Experience

Prior to joining Goodwin, Ms. Beman was a Special Assistant District Attorney in the Kings County District Attorney’s Office.

Recognition

While in law school, Ms. Beman was the Alumni Affairs Editor of the Connecticut Law Review.

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 2009
University of Connecticut School of Law

(honors)

B.S., Chemistry, 2006
Trinity College

Admissions

Bar

New York
Connecticut
Massachusetts
U.S. Patent and Trademark Office (USPTO)
Get In Touch
German Translation
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师